These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 15803935

  • 1. Mycophenolate mofetil and skin diseases.
    Hartmann M, Enk A.
    Lupus; 2005; 14 Suppl 1():s58-63. PubMed ID: 15803935
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate in dermatology.
    Liu V, Mackool BT.
    J Dermatolog Treat; 2003 Dec; 14(4):203-11. PubMed ID: 14660264
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M, David M, Mimouni D.
    Dermatol Clin; 2011 Oct; 29(4):555-9. PubMed ID: 21924997
    [Abstract] [Full Text] [Related]

  • 4. [Mycophenolate mofetil: a new immunosuppressive drug in dermatology and its possible uses].
    Geilen CC, Orfanos-Boeckel H, Offermann G, Orfanos CE.
    Hautarzt; 2000 Feb; 51(2):63-9. PubMed ID: 10743574
    [Abstract] [Full Text] [Related]

  • 5. Bullous systemic lupus erythematosus in a child responding to dapsone.
    Liu KL, Shen JL, Yang CS, Chen YJ.
    Pediatr Dermatol; 2014 Feb; 31(4):e104-6. PubMed ID: 24846529
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil and erythromycin for bullous lupus erythematosus of childhood.
    Pehr K.
    J Cutan Med Surg; 2012 Feb; 16(1):50-3. PubMed ID: 22417996
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate use in dermatology: a clinical audit.
    Li J, Chong AH, Green J, Kelly R, Baker C.
    Australas J Dermatol; 2013 Nov; 54(4):296-302. PubMed ID: 23574297
    [Abstract] [Full Text] [Related]

  • 8. Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses.
    Kitchin JE, Pomeranz MK, Pak G, Washenik K, Shupack JL.
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):445-9. PubMed ID: 9308561
    [Abstract] [Full Text] [Related]

  • 9. Treatment of chronic plaque-stage psoriasis and psoriatic arthritis with mycophenolate mofetil.
    Grundmann-Kollmann M, Mooser G, Schraeder P, Zollner T, Kaskel P, Ochsendorf F, Boehncke WH, Kerscher M, Kaufmann R, Peter RU.
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):835-7. PubMed ID: 10775866
    [Abstract] [Full Text] [Related]

  • 10. The use of cyclosporine in dermatology.
    Dehesa L, Abuchar A, Nuno-Gonzalez A, Vitiello M, Kerdel FA.
    J Drugs Dermatol; 2012 Aug; 11(8):979-87. PubMed ID: 22859244
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil for the management of autoimmune bullous diseases.
    Eskin-Schwartz M, David M, Mimouni D.
    Immunol Allergy Clin North Am; 2012 May; 32(2):309-15, vii. PubMed ID: 22560143
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil in pyoderma gangrenosum.
    Lee MR, Cooper AJ.
    J Dermatolog Treat; 2004 Sep; 15(5):303-7. PubMed ID: 15370398
    [Abstract] [Full Text] [Related]

  • 13. Successful treatment of linear IgA bullous dermatosis with mycophenolate mofetil.
    Gläser R, Sticherlin M.
    Acta Derm Venereol; 2002 Sep; 82(4):308-9. PubMed ID: 12361143
    [No Abstract] [Full Text] [Related]

  • 14. An analysis of the dermatological uses of mycophenolate mofetil in a tertiary hospital.
    George L, Hamann I, Chen K, Choi J, Fernandez-Peñas P.
    J Dermatolog Treat; 2015 Feb; 26(1):63-6. PubMed ID: 24286467
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil as therapy for pyoderma gangrenosum.
    Eaton PA, Callen JP.
    Arch Dermatol; 2009 Jul; 145(7):781-5. PubMed ID: 19620559
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil in autoimmune and inflammatory skin disorders.
    Nousari HC, Sragovich A, Kimyai-Asadi A, Orlinsky D, Anhalt GJ.
    J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):265-8. PubMed ID: 10025760
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of subacute cutaneous lupus erythematosus with mycophenolate mofetil.
    Schanz S, Ulmer A, Rassner G, Fierlbeck G.
    Br J Dermatol; 2002 Jul; 147(1):174-8. PubMed ID: 12100205
    [Abstract] [Full Text] [Related]

  • 18. The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum.
    Nousari HC, Lynch W, Anhalt GJ, Petri M.
    Arch Dermatol; 1998 Dec; 134(12):1509-11. PubMed ID: 9875186
    [No Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil and cyclosporin treatment for recalcitrant pyoderma gangrenosum.
    Hohenleutner U, Mohr VD, Michel S, Landthaler M.
    Lancet; 1997 Dec 13; 350(9093):1748. PubMed ID: 9413469
    [No Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis.
    Murray ML, Cohen JB.
    Clin Exp Dermatol; 2007 Jan 13; 32(1):23-7. PubMed ID: 17059445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.